Tirzepatide Shortage Resolved? FDA Says Yes, Compounders No

This post was originally published on Medscape

You will shortly be re-directed to the publisher's website

Tirzepatide injection (Zepbound, Mounjaro) is officially off the FDA’s drug shortage list, meaning compounders can no longer prepare and dispense the drug.
Medscape Medical News